By
Joseph Jankovic, MD, Distinguished Chair in Movement Disorders, Professor of Neurology and Director, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX
Alberto Albanese
M. Zouhair Atassi, PhD, DSc, Robert A. Welch Chair of Chemistry, Professor of Biochemistry and Molecular Biology, Professor of Immunology, Baylor College of Medicine, Houston, TX
J. Dolly
Mark Hallett, MD, Chief, Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Nathaniel Mayer
Description
The new, therapeutically-focused Botulinum Toxin presents comprehensive, cross-disciplinary guidance on current practices, covering more
than 100 non-cosmetic conditions that occur in neurology, physical medicine and rehabilitation, pain medicine, ophthalmology, gastroenterology,
urology, orthopedics, and surgery. International contributors review the current understanding of the biology and cellular mechanisms
along with relevant research so you can easily apply them to the pathophysiology of the numerous disorders that botulinum toxin is used
to treat—such as botulinum toxin applications for the treatment of cranial-cervical dystonias, motor disorders in cerebral palsy, bruxism
and temporomandibular disorders, headache, overactive bladder, chronic pelvic pain syndromes, arthritis joint pain, and wound healing.
With discussions of the latest in approved treatment practices as well as new and emerging uses, you’ll get in-depth management guidance
on the application of the toxin.
Audience:
Neurology
